Author(s)

S. Adadi¹, B. Bennani², M. Elabkari¹, A. Ibrahimi¹, S. Alaoui², M. Elkhadir², T. Harmouch³, M. Mahmoud⁴, C. Nejjari⁵, D. Benajah¹

¹Service of Hepatology and Gastroenterology, Hassan II University Hospital of Fez, University Sidi Mohamed Ben Abdellah, Fez, Morocco.
²Microbiology and Molecular Biology Laboratory, Hassan II University Hospital of Fez, University Sidi Mohamed Ben Abdellah, Fez, Morocco.
³Service of Pathology, Hassan II University Hospital of Fez, University Sidi Mohamed Ben Abdellah, Fez, Morocco.
⁴Service of Biology, Hassan II University Hospital of Fez, University Sidi Mohamed Ben Abdellah, Fez, Morocco.
⁵Service of épidémiology, Hassan II University Hospital of Fez, University Sidi Mohamed Ben Abdellah, Fez, Morocco.

Gastric atrophy and intestinal metaplasia represent the most important premalignant lesions in gastric carcinogenesis. The severity of gastric mucosal inflammation depends on the bacterium Helicobacter pylori (HP), on the host and on environmental factors. The aim of our study is to determine the prevalence and factors associated with Gastric atrophy and intestinal metaplasia in patients infected with Helicobacter pylori. Methods: This is a prospective study over a period of 4 years (May 2009 - January 2015) conducted in the service of Hepatology and Gastroenterology in hospital university Hassan II of Fez in collaboration with microbiology and molecular biology laboratory and epidemiology service of Faculty of Medicine and Pharmacy Fes. We included in our study all patients aged over 15 years, having ulcerative dyspepsia, peptic ulcer disease, gastritis or esophagitis. Results: During the study period, 1190 patients were included of which 70% had HP infection (N = 833). The average age was 48.21 years [16 - 99 years], sex ratio M/F was 1, 11. 60% of patients were older than 45 years. Chronic smoking was found in 12% of patients. Gastric atrophy was observed in 84% (N = 699) of patients infected with HP. Gastric atrophy was localized in 70% in the antrum and 30% in the fundus and 24% in both. The activity of gastritis (p = 0.0001) and the density of the HP (p = 0.005) were factors associated with atrophy. Intestinal metaplasia was observed in 13.5% of patients (N = 112). The density of HP (p = 0.037) and severe atrophy (p = 0.001) were factors associated with metaplasia. Other factors studied: age, sex, smoking, CagA⁺ genotype were not associated with either gastric atrophy or intestinal metaplasia. Conclusion: In our study, the prevalence of atrophic gastritis and intestinal metaplasia in patients infected with Helicobacter pylori was 84% and 13.5% respectively, which was a high prevalence. The activity of gastritis, and density of HP were factors associated with atrophy. The density of HP and severe atrophy were factors associated with metaplasia.

Gastric Atrophy, Intestinal Metaplasia, Helicobacter pylori, Gastritis

Adadi, S. , Bennani, B. , Elabkari, M. , Ibrahimi, A. , Alaoui, S. , Elkhadir, M. , Harmouch, T. , Mahmoud, M. , Nejjari, C. and Benajah, D. (2016) Gastric Atrophy, Intestinal Metaplasia in Helicobacter pylori Gastritis: Prevalence and Predictors Factors. Journal of Biosciences and Medicines, 4, 43-49. doi: 10.4236/jbm.2016.410005.